Clinical Trial Update: A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluating switching from cyclosporine to tacrolimus (prolonged-release or standard capsule) in kidney transplant recipients has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Recipients

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Astellas Pharma China, Inc. | Conditions: Kidney Transplant Recipients | Phase 4 | Status: TERMINATED